Imatinib in chronic myeloid leukemia: patient-reported side effects and their influence on quality of life
PAFMJ-Pakistan Armed Forces Medical Journal. 2018; 68 (3): 466-470
en Inglés
| IMEMR
| ID: emr-198838
ABSTRACT
Objective:
To evaluate side effects of Imatinib by patients of chronic myeloid leukemia and their influence on quality of life. StudyDesign:
Descriptive and analytic study. Place and Duration of Study The study was carried out at department of oncology CMH Rawalpindi, from Jan 2015 to Dec 2015
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Pak. Armed Forces Med. J.
Año:
2018
Similares
MEDLINE
...
LILACS
LIS